the stock has become expensive and is at channel resistance of 259-260 level .Sell with a price target of 232-35
AFTER TAKING SUPPORT AT 235 STOCK HEADING TOWARDS 282-85 LEVELS AND 3RD WAVE TRG OF 353 AS PER WAVE COUNT
Hikal announced the successful development of Favipiravir Active Pharmaceutical ingredient (API) and its intermediates the , In 5th wave after completing( i)st and ( ii)nd wave the ( iii)rd wave of 5th has a trg of 210.
highly oversold as suggested by RSI AND MACD, buy once crosses 98 as this might be end of wave c
itc is in a sideways trend .buy can be done with a stop of 202 and trg of 212.215, 220 but if breaks 199-202 range then going down to 183-185 not ruled out.
we are near to completion of 2nd wave and MACD ,RSI all suggesting it fibo retracement and 3rd wave suggesting 1st trg of 250-60
deepak which has a long first wave and second wave is small as per fibo extension trg longs comes to 352 . after crossing 179-80 range stock will show real power and wll target 197 minimum
after making inverse head and shoulder formation and breakout from range of 131 to 150 range it will target 187 with fibo etension.
AFTER showing very good result BASF shares took a quantum jump from 1650 approx to 2000 rs.In the days to come fib extension is showing a price trg of 2510 to 2550 .
minimum target in long run of 863. and 672 is the channel resistance rising on volume increase of 200 %
INVERSE HEAD AND SHOULDER FORMATION ONCE CROSSES 150 WILL SHOW REAL POWER TRGET OF 180/240
3RD OF 3RD WAVE IN PROGRESS WILL SHOW REAL POWER ONCE IT CROSSES 143-50 LEVEL. IT HAS A MINIMUM TRG OF 188,240.270